Entities / Company
Novo Holdings.
Danish company
- Reports this week
- 0
- Active events
- 0
- Connections
- 21
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Gone quiet
No new reports in 90+ days-
Novo Holdings is undergoing a leadership transition and is currently seeking strategic guidance and support from Reunion Neuroscience, Inc.Some support2 reports
-
The FDA accepted a revised approval submission regarding a Biohaven drug, while simultaneously canceling advisory committee discussions. This occurred amidst corporate restructuring, including Novo Holdings acquiring Catalent, which has a gene therapy facility in Baltimore.Some support1 report
No events began in the chosen period. Widen it, or reset.
Connections
The 2 strongest of 21, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.History
Events by the month they beganJune 2026
2 events- Novo Holdings is undergoing a leadership transition and is currently seeking strategic guidance and support from Reunion Neuroscience, Inc.
- The FDA accepted a revised approval submission regarding a Biohaven drug, while simultaneously canceling advisory committee discussions. This occurred amidst corporate restructuring, including Novo Holdings acquiring Catalent, which has a gene therapy facility in Baltimore.